Genentech, Inc.
News published by Genentech, Inc., officials updates activities
Published in Medical Patent Week, April 29th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Genentech, Inc.
Report 1: Genentech, Inc. (NYSE:DNA) announced that the U.S. Patent and Trademark Office issued a final Office action in its reexamination of the Cabilly, et al. U.S. Patent No. 6,331,415 ('415 patent) and rejected the patentability of the claims of the '415 patent. Genentech plans to respond to the final Office action within the next several months and, if necessary, appeal the decision through all appropriate means of review within the Patent Office and the courts. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week
Source: Medical Patent Week (2007-04-29)
More Articles from Medical Patent Week
- Angiography
Data from University of Illinois, Department of Neurosurgery advance knowledge in angiography - Bioscience
New European ARA Infant Formula Patent Strengthens Martek's Intellectual Property Position - Biotechnology
India's biotech industry emerging as world innovator, collaborator, competitor - Capillary Electrophoresis
Transgenomic, Inc. Purchases Certain Assets and Signs Licenses to Supply Customers of SpectruMedix LLC - Diagnostics
Roche to acquire BioVeris to expand its leading ECL immunochemistry business into new market segments - Drug Delivery
Apogee Signs Exclusive License With Georgia Tech for Microneedle Technology - More from this issue of Medical Patent Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
